It is a pharma private limited company based in Hyderabad, Telangana, India, established in 2014.
2014 | Hyderabad, Telangana, India | ActiveIndo-Swiss Remedies Private Limited, a active private limited company, was established on 04 August 2014 in Hyderabad, Telangana, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U24240TG2014PTC095123. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹0.40 M and a paid-up capital of ₹0.40 M.
It upholds a compliant status. Its leadership includes Devendar Rao Thutika (Director), Sushma Reddy Gujjula (Director), Saritha Bachu (Director). Past directors included Rajaram Reddy Solvpapi, Nandakishore Kumar Ganapathi. It holds ₹3.00 M open charges and ₹3.00 M settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at H No 35-5-35/136A, Plot No 158 Prasanthnagar Colony, Kukatpally, Balana, Gar Mandal, Hyderabad, Telangana, 500072.
U24240TG2014PTC095123
095123
04 August 2014
₹0.40 M
₹0.40 M
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Indo-Swiss Remedies Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Devendar Rao Thutika | Director | 04 Aug 2014 | Current |
| Sushma Reddy Gujjula | Director | 30 Sep 2017 | Current |
| Saritha Bachu | Director | 25 Dec 2024 | Current |
| Narsimha Reddy Bommineni | Director | 04 Aug 2014 | Current |
| Vikas Reddy Andru | Director | 14 Aug 2025 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 02 Jan 2025 | Past |
| Pramod Abcsdd | Director | 18 Aug 2025 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Indo-Swiss Remedies Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 92.73% increase. The company also saw a substantial improvement in profitability, with a 120.21% increase in profit. The company's net worth moved up by a moderate rise of 9.83%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2020, Indo-Swiss Remedies had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹3,000,000.00
₹3,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 18 May 2018 | Others | ₹3.00 M | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Indo-Swiss Remedies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Indo-Swiss Remedies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Indo-Swiss Remedies's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Vikas Reddy Andru was appointed as a Director was appointed as a Director on 14 Aug 2025 & has been associated with this company since 4 months 8 days . was documented.
Saritha Bachu was appointed as a Director was appointed as a Director on 25 Dec 2024 & has been associated with this company since 11 months 26 days . was recorded as a recent event.
Progress on A charge registered on 18 May 2018 via Charge ID 100206528 with Others was fully satisfied on 11 Dec 2024. was documented.
Indo-Swiss Remedies Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
Indo-Swiss Remedies Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was recorded as a recent event.
A charge with Others amounted to Rs. 3.00 M with Charge ID 100206528 was registered on 18 May 2018. was recorded as a recent event.
The CIN of Indo-Swiss Remedies Private Limited is U24240TG2014PTC095123.
Indo-Swiss Remedies Private Limited is headquartered at H No 35-5-35/136A, Plot No 158 Prasanthnagar Colony, Kukatpally, Balana, Gar Mandal, Hyderabad, Telangana, 500072.
Indo-Swiss Remedies Private Limited was incorporated on 04 August 2014.
The current directors of Indo-Swiss Remedies Private Limited are
The primary industry of Indo-Swiss Remedies Private Limited is Trade.
Indo-Swiss Remedies Private Limited is unlisted.
The authorized capital of Indo-Swiss Remedies Private Limited is ₹0.40 M, and the paid-up capital is ₹0.40 M.
The compliance status of Indo-Swiss Remedies Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX